Orthopedic Implant Antibacterial Coatings Surface Treatment Market Size and Share by 2026

Upcoming

2023

Orthopedic Implant Antibacterial Coatings Surface Treatment Market

by Type (Passive Surface Finishing/Modifications (PSM), Active Surface Finishing/Modifications (ASM), Peri-Operative Antibacterial Local Carriers or Coatings (LCC)): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals	Report Code: A02605	Nov 2023 \| Pages: NA
Tables: NA	Charts: NA	Formats*: Single User License, Five User License & Enterprise User License Data Pack Excel License It comes with the additional cost of $2500.00 contact sales.

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Orthopedic Implant Antibacterial Coatings Surface Treatment Market

Request Now !

Orthopedic implants containing antibacterial coating inhibits the growth of microorganism on the implants to prevent infection within the body. Growth in awareness regarding bacterial infections, increase in demand for coated implants to prevent infection, and rise in prevalence of bacterial infections drive the market growth. However, health concerns using titanium as a coating material for implants and high cost of coatings restrain the market growth. Moreover, development of effective antibacterial implants and growth opportunities in the emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for the market growth during the forecast period.

The global orthopedic implant antibacterial coatings surface treatment market is segmented on the basis of type and geography. On the basis of type, it is divided into passive surface finishing/modifications (PSM), active surface finishing/modifications (ASM), and peri-operative antibacterial local carriers or coatings (LCC). By geography, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Some of the key players in the market are Pertinax Pharma Limited, HeiQ Materials AG, Ai2 Ltd, Microbe Investigations AG, Curza, BioCote Limited, Allvivo Vascular, Inc., Matera, Agienic Inc., and Kastus.

Key Benefits

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
Key players are profiled and their strategies are analyzed thoroughly, which explains the competitive outlook of the global market.
The report offers a quantitative analysis to enable the stakeholders to capitalize on the prevailing market opportunities.
Analysis by type helps understand the types of antibacterial coatings used and the variants that are expected to gain prominence in the future.

Orthopedic Implant Antibacterial Coatings Surface Treatment Market Report Highlights

Aspects	Details
By Type	Passive Surface Finishing/Modifications (PSM) Active Surface Finishing/Modifications (ASM) Peri-Operative Antibacterial Local Carriers or Coatings (LCC)
By Region	North America (U.S., Canada, Mexico) Europe (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	BioCote Limited, Pertinax Pharma Limited, Allvivo Vascular, Inc., Kastus, Ai2 Ltd., Matera, HeiQ Materials AG, Microbe Investigations AG, Curza, Agienic Inc.

CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
  - 1.4.1. Primary Research
  - 1.4.2. Secondary Research
  - 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
  - 3.2.1. Top Investment Pockets
  - 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
  - 3.3.1. Bargaining Power of Suppliers
  - 3.3.2. Threat of New Entrants
  - 3.3.3. Threat of Substitutes
  - 3.3.4. Competitive Rivalry
  - 3.3.5. Bargaining Power among Buyers
- 3.5. Market Dynamics
  - 3.5.1. Drivers
  - 3.5.2. Restraints
  - 3.5.3. Opportunities
- 3.6. COVID-19 Impact Analysis
CHAPTER 4: ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET, BY TYPE
- 4.1. Market Overview
  - 4.1.1 Market Size and Forecast, By Type
- 4.2. Passive Surface Finishing/Modifications (PSM)
  - 4.2.1. Key Market Trends, Growth Factors and Opportunities
  - 4.2.2. Market Size and Forecast, By Region
  - 4.2.3. Market Share Analysis, By Country
- 4.3. Active Surface Finishing/Modifications (ASM)
  - 4.3.1. Key Market Trends, Growth Factors and Opportunities
  - 4.3.2. Market Size and Forecast, By Region
  - 4.3.3. Market Share Analysis, By Country
- 4.4. Peri-Operative Antibacterial Local Carriers Or Coatings (LCC)
  - 4.4.1. Key Market Trends, Growth Factors and Opportunities
  - 4.4.2. Market Size and Forecast, By Region
  - 4.4.3. Market Share Analysis, By Country
CHAPTER 5: ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET, BY REGION
- 5.1. Market Overview
  - 5.1.1 Market Size and Forecast, By Region
- 5.2. North America
  - 5.2.1. Key Market Trends and Opportunities
  - 5.2.2. Market Size and Forecast, By Type
  - 5.2.3. Market Size and Forecast, By Country
  - 5.2.4. U.S. Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.2.4.1. Market Size and Forecast, By Type
  - 5.2.5. Canada Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.2.5.1. Market Size and Forecast, By Type
  - 5.2.6. Mexico Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.2.6.1. Market Size and Forecast, By Type
- 5.3. Europe
  - 5.3.1. Key Market Trends and Opportunities
  - 5.3.2. Market Size and Forecast, By Type
  - 5.3.3. Market Size and Forecast, By Country
  - 5.3.4. France Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.3.4.1. Market Size and Forecast, By Type
  - 5.3.5. Germany Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.3.5.1. Market Size and Forecast, By Type
  - 5.3.6. Italy Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.3.6.1. Market Size and Forecast, By Type
  - 5.3.7. Spain Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.3.7.1. Market Size and Forecast, By Type
  - 5.3.8. UK Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.3.8.1. Market Size and Forecast, By Type
  - 5.3.9. Russia Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.3.9.1. Market Size and Forecast, By Type
  - 5.3.10. Rest Of Europe Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.3.10.1. Market Size and Forecast, By Type
- 5.4. Asia-Pacific
  - 5.4.1. Key Market Trends and Opportunities
  - 5.4.2. Market Size and Forecast, By Type
  - 5.4.3. Market Size and Forecast, By Country
  - 5.4.4. China Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.4.4.1. Market Size and Forecast, By Type
  - 5.4.5. Japan Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.4.5.1. Market Size and Forecast, By Type
  - 5.4.6. India Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.4.6.1. Market Size and Forecast, By Type
  - 5.4.7. South Korea Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.4.7.1. Market Size and Forecast, By Type
  - 5.4.8. Australia Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.4.8.1. Market Size and Forecast, By Type
  - 5.4.9. Thailand Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.4.9.1. Market Size and Forecast, By Type
  - 5.4.10. Malaysia Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.4.10.1. Market Size and Forecast, By Type
  - 5.4.11. Indonesia Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.4.11.1. Market Size and Forecast, By Type
  - 5.4.12. Rest of Asia Pacific Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.4.12.1. Market Size and Forecast, By Type
- 5.5. LAMEA
  - 5.5.1. Key Market Trends and Opportunities
  - 5.5.2. Market Size and Forecast, By Type
  - 5.5.3. Market Size and Forecast, By Country
  - 5.5.4. Brazil Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.5.4.1. Market Size and Forecast, By Type
  - 5.5.5. South Africa Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.5.5.1. Market Size and Forecast, By Type
  - 5.5.6. Saudi Arabia Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.5.6.1. Market Size and Forecast, By Type
  - 5.5.7. UAE Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.5.7.1. Market Size and Forecast, By Type
  - 5.5.8. Argentina Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.5.8.1. Market Size and Forecast, By Type
  - 5.5.9. Rest of LAMEA Orthopedic Implant Antibacterial Coatings Surface Treatment Market
    - 5.5.9.1. Market Size and Forecast, By Type
CHAPTER 6: COMPETITIVE LANDSCAPE
- 6.1. Introduction
- 6.2. Top Winning Strategies
- 6.3. Product Mapping Of Top 10 Player
- 6.4. Competitive Dashboard
- 6.5. Competitive Heatmap
- 6.6. Top Player Positioning,2022
CHAPTER 7: COMPANY PROFILES
- 7.1. Pertinax Pharma Limited
  - 7.1.1. Company Overview
  - 7.1.2. Key Executives
  - 7.1.3. Company Snapshot
  - 7.1.4. Operating Business Segments
  - 7.1.5. Product Portfolio
  - 7.1.6. Business Performance
  - 7.1.7. Key Strategic Moves and Developments
- 7.2. HeiQ Materials AG
  - 7.2.1. Company Overview
  - 7.2.2. Key Executives
  - 7.2.3. Company Snapshot
  - 7.2.4. Operating Business Segments
  - 7.2.5. Product Portfolio
  - 7.2.6. Business Performance
  - 7.2.7. Key Strategic Moves and Developments
- 7.3. Ai2 Ltd.
  - 7.3.1. Company Overview
  - 7.3.2. Key Executives
  - 7.3.3. Company Snapshot
  - 7.3.4. Operating Business Segments
  - 7.3.5. Product Portfolio
  - 7.3.6. Business Performance
  - 7.3.7. Key Strategic Moves and Developments
- 7.4. Microbe Investigations AG
  - 7.4.1. Company Overview
  - 7.4.2. Key Executives
  - 7.4.3. Company Snapshot
  - 7.4.4. Operating Business Segments
  - 7.4.5. Product Portfolio
  - 7.4.6. Business Performance
  - 7.4.7. Key Strategic Moves and Developments
- 7.5. Curza
  - 7.5.1. Company Overview
  - 7.5.2. Key Executives
  - 7.5.3. Company Snapshot
  - 7.5.4. Operating Business Segments
  - 7.5.5. Product Portfolio
  - 7.5.6. Business Performance
  - 7.5.7. Key Strategic Moves and Developments
- 7.6. BioCote Limited
  - 7.6.1. Company Overview
  - 7.6.2. Key Executives
  - 7.6.3. Company Snapshot
  - 7.6.4. Operating Business Segments
  - 7.6.5. Product Portfolio
  - 7.6.6. Business Performance
  - 7.6.7. Key Strategic Moves and Developments
- 7.7. Allvivo Vascular, Inc.
  - 7.7.1. Company Overview
  - 7.7.2. Key Executives
  - 7.7.3. Company Snapshot
  - 7.7.4. Operating Business Segments
  - 7.7.5. Product Portfolio
  - 7.7.6. Business Performance
  - 7.7.7. Key Strategic Moves and Developments
- 7.8. Matera
  - 7.8.1. Company Overview
  - 7.8.2. Key Executives
  - 7.8.3. Company Snapshot
  - 7.8.4. Operating Business Segments
  - 7.8.5. Product Portfolio
  - 7.8.6. Business Performance
  - 7.8.7. Key Strategic Moves and Developments
- 7.9. Agienic Inc.
  - 7.9.1. Company Overview
  - 7.9.2. Key Executives
  - 7.9.3. Company Snapshot
  - 7.9.4. Operating Business Segments
  - 7.9.5. Product Portfolio
  - 7.9.6. Business Performance
  - 7.9.7. Key Strategic Moves and Developments
- 7.10. Kastus
  - 7.10.1. Company Overview
  - 7.10.2. Key Executives
  - 7.10.3. Company Snapshot
  - 7.10.4. Operating Business Segments
  - 7.10.5. Product Portfolio
  - 7.10.6. Business Performance
  - 7.10.7. Key Strategic Moves and Developments

LIST OF TABLES
TABLE 1. GLOBAL ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 2. GLOBAL ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET FOR PASSIVE SURFACE FINISHING/MODIFICATIONS (PSM), BY REGION, 2022-2032 ($MILLION)
TABLE 3. GLOBAL ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET FOR ACTIVE SURFACE FINISHING/MODIFICATIONS (ASM), BY REGION, 2022-2032 ($MILLION)
TABLE 4. GLOBAL ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET FOR PERI-OPERATIVE ANTIBACTERIAL LOCAL CARRIERS OR COATINGS (LCC), BY REGION, 2022-2032 ($MILLION)
TABLE 5. GLOBAL ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 6. NORTH AMERICA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 7. NORTH AMERICA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 8. U.S. ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 9. CANADA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 10. MEXICO ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 11. EUROPE ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 12. EUROPE ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 13. FRANCE ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 14. GERMANY ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 15. ITALY ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 16. SPAIN ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 17. UK ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 18. RUSSIA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 19. REST OF EUROPE ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 20. ASIA-PACIFIC ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 21. ASIA-PACIFIC ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 22. CHINA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 23. JAPAN ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 24. INDIA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 25. SOUTH KOREA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 26. AUSTRALIA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 27. THAILAND ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 28. MALAYSIA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 29. INDONESIA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 30. REST OF ASIA PACIFIC ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 31. LAMEA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 32. LAMEA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 33. BRAZIL ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 34. SOUTH AFRICA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 35. SAUDI ARABIA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 36. UAE ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 37. ARGENTINA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 38. REST OF LAMEA ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT, BY TYPE, 2022-2032 ($MILLION)
TABLE 39. PERTINAX PHARMA LIMITED: KEY EXECUTIVES
TABLE 40. PERTINAX PHARMA LIMITED: COMPANY SNAPSHOT
TABLE 41. PERTINAX PHARMA LIMITED: OPERATING SEGMENTS
TABLE 42. PERTINAX PHARMA LIMITED: PRODUCT PORTFOLIO
TABLE 43. PERTINAX PHARMA LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 44. HEIQ MATERIALS AG: KEY EXECUTIVES
TABLE 45. HEIQ MATERIALS AG: COMPANY SNAPSHOT
TABLE 46. HEIQ MATERIALS AG: OPERATING SEGMENTS
TABLE 47. HEIQ MATERIALS AG: PRODUCT PORTFOLIO
TABLE 48. HEIQ MATERIALS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 49. AI2 LTD.: KEY EXECUTIVES
TABLE 50. AI2 LTD.: COMPANY SNAPSHOT
TABLE 51. AI2 LTD.: OPERATING SEGMENTS
TABLE 52. AI2 LTD.: PRODUCT PORTFOLIO
TABLE 53. AI2 LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 54. MICROBE INVESTIGATIONS AG: KEY EXECUTIVES
TABLE 55. MICROBE INVESTIGATIONS AG: COMPANY SNAPSHOT
TABLE 56. MICROBE INVESTIGATIONS AG: OPERATING SEGMENTS
TABLE 57. MICROBE INVESTIGATIONS AG: PRODUCT PORTFOLIO
TABLE 58. MICROBE INVESTIGATIONS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 59. CURZA: KEY EXECUTIVES
TABLE 60. CURZA: COMPANY SNAPSHOT
TABLE 61. CURZA: OPERATING SEGMENTS
TABLE 62. CURZA: PRODUCT PORTFOLIO
TABLE 63. CURZA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 64. BIOCOTE LIMITED: KEY EXECUTIVES
TABLE 65. BIOCOTE LIMITED: COMPANY SNAPSHOT
TABLE 66. BIOCOTE LIMITED: OPERATING SEGMENTS
TABLE 67. BIOCOTE LIMITED: PRODUCT PORTFOLIO
TABLE 68. BIOCOTE LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 69. ALLVIVO VASCULAR, INC.: KEY EXECUTIVES
TABLE 70. ALLVIVO VASCULAR, INC.: COMPANY SNAPSHOT
TABLE 71. ALLVIVO VASCULAR, INC.: OPERATING SEGMENTS
TABLE 72. ALLVIVO VASCULAR, INC.: PRODUCT PORTFOLIO
TABLE 73. ALLVIVO VASCULAR, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 74. MATERA: KEY EXECUTIVES
TABLE 75. MATERA: COMPANY SNAPSHOT
TABLE 76. MATERA: OPERATING SEGMENTS
TABLE 77. MATERA: PRODUCT PORTFOLIO
TABLE 78. MATERA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 79. AGIENIC INC.: KEY EXECUTIVES
TABLE 80. AGIENIC INC.: COMPANY SNAPSHOT
TABLE 81. AGIENIC INC.: OPERATING SEGMENTS
TABLE 82. AGIENIC INC.: PRODUCT PORTFOLIO
TABLE 83. AGIENIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 84. KASTUS: KEY EXECUTIVES
TABLE 85. KASTUS: COMPANY SNAPSHOT
TABLE 86. KASTUS: OPERATING SEGMENTS
TABLE 87. KASTUS: PRODUCT PORTFOLIO
TABLE 88. KASTUS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES
FIGURE 1. GLOBAL ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET SEGMENTATION
FIGURE 2. GLOBAL ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET
FIGURE 3. SEGMENTATION ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET
FIGURE 4. TOP INVESTMENT POCKET IN ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET
FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
FIGURE 8. LOW THREAT OF SUBSTITUTION
FIGURE 9. HIGH COMPETITIVE RIVALRY
FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET
FIGURE 11. ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET SEGMENTATION, BY BY TYPE
FIGURE 12. ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET FOR PASSIVE SURFACE FINISHING/MODIFICATIONS (PSM), BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 13. ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET FOR ACTIVE SURFACE FINISHING/MODIFICATIONS (ASM), BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 14. ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET FOR PERI-OPERATIVE ANTIBACTERIAL LOCAL CARRIERS OR COATINGS (LCC), BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 15. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
FIGURE 16. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
FIGURE 17. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
FIGURE 18. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 19. COMPETITIVE DASHBOARD
FIGURE 20. COMPETITIVE HEATMAP: ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET
FIGURE 21. Top player positioning, 2022
FIGURE 22. PERTINAX PHARMA LIMITED: NET SALES, 2020-2022 ($MILLION)
FIGURE 23. PERTINAX PHARMA LIMITED: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 24. PERTINAX PHARMA LIMITED: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 25. HEIQ MATERIALS AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 26. HEIQ MATERIALS AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 27. HEIQ MATERIALS AG: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 28. AI2 LTD.: NET SALES, 2020-2022 ($MILLION)
FIGURE 29. AI2 LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 30. AI2 LTD.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 31. MICROBE INVESTIGATIONS AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 32. MICROBE INVESTIGATIONS AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 33. MICROBE INVESTIGATIONS AG: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 34. CURZA: NET SALES, 2020-2022 ($MILLION)
FIGURE 35. CURZA: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 36. CURZA: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 37. BIOCOTE LIMITED: NET SALES, 2020-2022 ($MILLION)
FIGURE 38. BIOCOTE LIMITED: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 39. BIOCOTE LIMITED: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 40. ALLVIVO VASCULAR, INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 41. ALLVIVO VASCULAR, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 42. ALLVIVO VASCULAR, INC.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 43. MATERA: NET SALES, 2020-2022 ($MILLION)
FIGURE 44. MATERA: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 45. MATERA: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 46. AGIENIC INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 47. AGIENIC INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 48. AGIENIC INC.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 49. KASTUS: NET SALES, 2020-2022 ($MILLION)
FIGURE 50. KASTUS: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 51. KASTUS: REVENUE SHARE, BY REGION, 2032 (%)

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

U.S.-Canada Toll-free: +1-800-792-5285
Int'l :	+1-503-894-6022
Europe :	+44-845-528-1300
Email :	help@alliedmarketresearch.com

Life Sciences	Construction & Manufacturing	Semiconductor & Electronics
Consumer Goods	Food & Beverages	Automotive & Tarnsportation
Materials & Chemicals	Energy & Power	ICT & Media
Aerospace & Defense	BFSI
You must check at least one industry.

Your Shopping Cart Is Empty

Continue Shopping

Orthopedic Implant Antibacterial Coatings Surface Treatment Market Global Opportunity Analysis and Industry Forecast, 2023-2032

2023

Orthopedic Implant Antibacterial Coatings Surface Treatment Market

Orthopedic Implant Antibacterial Coatings Surface Treatment Market

by Type (Passive Surface Finishing/Modifications (PSM), Active Surface Finishing/Modifications (ASM), Peri-Operative Antibacterial Local Carriers or Coatings (LCC)): Global Opportunity Analysis and Industry Forecast, 2023-2032

COVID-19

CHAPTER 1: INTRODUCTION

1.1. Report Description

1.2. Key Market Segments

1.3. Key Benefits

1.4. Research Methodology

1.4.1. Primary Research

1.4.2. Secondary Research

1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope

3.2. Key Findings

3.2.1. Top Investment Pockets

3.2.2. Top Winning Strategies

3.3. Porter's Five Forces Analysis

3.3.1. Bargaining Power of Suppliers

3.3.2. Threat of New Entrants

3.3.3. Threat of Substitutes

3.3.4. Competitive Rivalry

3.3.5. Bargaining Power among Buyers

3.5. Market Dynamics

3.5.1. Drivers

3.5.2. Restraints

3.5.3. Opportunities

3.6. COVID-19 Impact Analysis

CHAPTER 4: ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET, BY TYPE

4.1. Market Overview

4.1.1 Market Size and Forecast, By Type

4.2. Passive Surface Finishing/Modifications (PSM)

4.2.1. Key Market Trends, Growth Factors and Opportunities

4.2.2. Market Size and Forecast, By Region

4.2.3. Market Share Analysis, By Country

4.3. Active Surface Finishing/Modifications (ASM)

4.3.1. Key Market Trends, Growth Factors and Opportunities

4.3.2. Market Size and Forecast, By Region

4.3.3. Market Share Analysis, By Country

4.4. Peri-Operative Antibacterial Local Carriers Or Coatings (LCC)

4.4.1. Key Market Trends, Growth Factors and Opportunities

4.4.2. Market Size and Forecast, By Region

4.4.3. Market Share Analysis, By Country

CHAPTER 5: ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET, BY REGION

5.1. Market Overview

5.1.1 Market Size and Forecast, By Region

5.2. North America

5.2.1. Key Market Trends and Opportunities

5.2.2. Market Size and Forecast, By Type

5.2.3. Market Size and Forecast, By Country

5.2.4. U.S. Orthopedic Implant Antibacterial Coatings Surface Treatment Market

5.2.4.1. Market Size and Forecast, By Type

5.2.5. Canada Orthopedic Implant Antibacterial Coatings Surface Treatment Market

5.2.5.1. Market Size and Forecast, By Type

5.2.6. Mexico Orthopedic Implant Antibacterial Coatings Surface Treatment Market

5.2.6.1. Market Size and Forecast, By Type

5.3. Europe

5.3.1. Key Market Trends and Opportunities

5.3.2. Market Size and Forecast, By Type

5.3.3. Market Size and Forecast, By Country

5.3.4. France Orthopedic Implant Antibacterial Coatings Surface Treatment Market

5.3.4.1. Market Size and Forecast, By Type

5.3.5. Germany Orthopedic Implant Antibacterial Coatings Surface Treatment Market

5.3.5.1. Market Size and Forecast, By Type

5.3.6. Italy Orthopedic Implant Antibacterial Coatings Surface Treatment Market

5.3.6.1. Market Size and Forecast, By Type

5.3.7. Spain Orthopedic Implant Antibacterial Coatings Surface Treatment Market

5.3.7.1. Market Size and Forecast, By Type

5.3.8. UK Orthopedic Implant Antibacterial Coatings Surface Treatment Market

5.3.8.1. Market Size and Forecast, By Type

5.3.9. Russia Orthopedic Implant Antibacterial Coatings Surface Treatment Market

5.3.9.1. Market Size and Forecast, By Type

5.3.10. Rest Of Europe Orthopedic Implant Antibacterial Coatings Surface Treatment Market

5.3.10.1. Market Size and Forecast, By Type

Orthopedic Implant Antibacterial Coatings Surface Treatment Market
Global Opportunity Analysis and Industry Forecast, 2023-2032